Hakon Invest guarantees its share, 68.5%, in the forthcoming preferential rights issue in Hemtex. The total capital contribution in the new share issue amounts to approximately SEK 325 M. For more information, contact: Head of Investor Relations Cecilia Lannebo Phone: +46-8-55 33 99 Email:cecilia.lannebo@hakoninvest.se The information is that which Hakon Invest AB is required to declare by the Securities Business Act and/or the Financial instruments Trading Act. The information was submitted for publication on February 15 at 07.02 CET. [HUG#1488764]
Hakon Invest guarantees its share in Hemtex new share issue
| Source: ICA Gruppen AB